Follow
Svasti Haricharan
Svasti Haricharan
Sanford Burnham Prebys Medical Discovery Institute
Verified email at sbpdiscovery.org
Title
Cited by
Cited by
Year
STAT signaling in mammary gland differentiation, cell survival and tumorigenesis
S Haricharan, Y Li
Molecular and cellular endocrinology 382 (1), 560-569, 2014
1422014
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
S Haricharan, MN Bainbridge, P Scheet, PH Brown
Breast cancer research and treatment 146, 211-220, 2014
1182014
Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer
JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ...
Cell reports 24 (6), 1434-1444. e7, 2018
942018
Endocrine therapy resistance: new insights
JT Lei, M Anurag, S Haricharan, X Gou, MJ Ellis
The Breast 48, S26-S30, 2019
872019
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth
S Haricharan, P Brown
Proceedings of the National Academy of Sciences 112 (25), E3216-E3225, 2015
832015
Comprehensive profiling of DNA repair defects in breast cancer identifies a novel class of endocrine therapy resistance drivers
M Anurag, N Punturi, J Hoog, MN Bainbridge, MJ Ellis, S Haricharan
Clinical Cancer Research 24 (19), 4887-4899, 2018
772018
Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer
S Haricharan, N Punturi, P Singh, KR Holloway, M Anurag, J Schmelz, ...
Cancer discovery 7 (10), 1168-1183, 2017
752017
Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation
JP Reddy, S Peddibhotla, W Bu, J Zhao, S Haricharan, YCN Du, ...
Proceedings of the National Academy of Sciences 107 (8), 3728-3733, 2010
592010
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy
S Haricharan, J Dong, S Hein, JP Reddy, Z Du, M Toneff, K Holloway, ...
Elife 2, e00996, 2013
552013
Segregating YKU80 and TLC1 alleles underlying natural variation in telomere properties in wild yeast
G Liti, S Haricharan, FA Cubillos, AL Tierney, S Sharp, AA Bertuch, ...
PLoS genetics 5 (9), e1000659, 2009
542009
Ku must load directly onto the chromosome end in order to mediate its telomeric functions
CR Lopez, A Ribes-Zamora, SM Indiviglio, CL Williams, S Haricharan, ...
PLoS genetics 7 (8), e1002233, 2011
492011
Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress
SM Hein, S Haricharan, AN Johnston, MJ Toneff, JP Reddy, J Dong, W Bu, ...
Oncogene 35 (11), 1461-1467, 2016
422016
DNA damage repair defects as a new class of endocrine treatment resistance driver
M Anurag, MJ Ellis, S Haricharan
Oncotarget 9 (91), 36252, 2018
402018
RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
A Garancher, H Suzuki, S Haricharan, LQ Chau, MB Masihi, JM Rusert, ...
Nature neuroscience 23 (7), 842-853, 2020
372020
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
E Sajjadi, K Venetis, R Piciotti, M Invernizzi, E Guerini-Rocco, ...
Cancer Cell International 21, 1-10, 2021
302021
Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers
K Venetis, E Sajjadi, S Haricharan, N Fusco
Translational Cancer Research 9 (7), 4060, 2020
282020
CDK4/6 inhibitor biomarker research: are we barking up the wrong tree?
M Anurag, S Haricharan, MJ Ellis
Clinical Cancer Research 26 (1), 3-5, 2020
222020
Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer
S Haricharan, SM Hein, J Dong, MJ Toneff, OH Aina, PH Rao, RD Cardiff, ...
Oncogene 33 (50), 5729-5739, 2014
192014
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ...
Nature communications 12 (1), 2940, 2021
152021
Decellularized organ biomatrices facilitate quantifiable in vitro 3D cancer metastasis models
SN VandenHeuvel, HA Farris, DA Noltensmeyer, S Roy, DA Donehoo, ...
Soft Matter 18 (31), 5791-5806, 2022
112022
The system can't perform the operation now. Try again later.
Articles 1–20